2,887
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Low intensity pulsed ultrasound promotes the migration of bone marrow- derived mesenchymal stem cells via activating FAK-ERK1/2 signalling pathway

, , , , ORCID Icon, & ORCID Icon show all
Pages 3603-3613 | Received 17 Jul 2019, Accepted 11 Aug 2019, Published online: 30 Aug 2019

References

  • Schmidt M, Breyer S, Löbel U, et al. Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation. Orphanet J Rare Dis. 2016;11:93.
  • Song CG, Zhang YZ, Wu HN, et al. Stem cells: a promising candidate to treat neurological disorders. Neural Regen Res. 2018;13:1294–1304.
  • Derubeis AR, Cancedda R. Bone marrow stromal cells (BMSCs) in bone engineering: limitations and recent advances. Ann Biomed Eng. 2004;32:160–165.
  • Deak E, Seifried E, Henschler R. Homing pathways of mesenchymal stromal cells (MSCs) and their role in clinical applications. Int Rev Immunol. 2010;29:16.
  • Armiñán A, Gandía C, García-Verdugo JM, et al. Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction. J Am Coll Cardiol. 2010;55:2244–2253.
  • Gleeson BM, Martin K, Ali MT, et al. Bone marrow‐derived mesenchymal stem cells have innate procoagulant activity and cause microvascular obstruction following intracoronary delivery: amelioration by antithrombin therapy. Stem Cells. 2015;33:2726–2737.
  • Lee RH, Pulin AA, Min JS, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009;5:54–63.
  • Schrepfer S, Deuse T, Reichenspurner H, et al. Stem cell transplantation: the lung barrier. Transplant Proc. 2007;39:573–576.
  • Walczak P, Zhang J, Gilad AA, et al. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke. 2008;39:1569–1574.
  • Zhang D, Fan GC, Zhou X, et al. Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. J Mol Cell Cardiol. 2008;44:281–292.
  • Bacou F, el Andalousi RB, Daussin PA, et al. Transplantation of adipose tissue-derived stromal cells increases mass and functional capacity of damaged skeletal muscle. Cell Transplant. 2004;13:103–111.
  • A S, Cm V. Mesenchymal stem cells migration homing and tracking. Stem Cells Int. 2013;2013:130763.
  • Shan PY, Zheng W, Ling W. Preconditioning strategy in stem cell transplantation therapy. Transl. Stroke Res. 2013;4:76–88.
  • Ling L, Wei T, He L, et al. Low-intensity pulsed ultrasound activates ERK1/2 and PI3K-Akt signalling pathways and promotes the proliferation of human amnion-derived mesenchymal stem cells. Cell Prolif. 2017;50:e12383.
  • Ruixin H, Weichen Z, Yu Z, et al. Combination of low-intensity pulsed ultrasound and C3H10T1/2 cells promotes bone-defect healing. Int Orthop. 2015;39:2181–2189.
  • Ruixin H, Junlin C, Jingwei J, et al. Synergies of accelerating differentiation of bone marrow mesenchymal stem cells induced by low intensity pulsed ultrasound, osteogenic and endothelial inductive agent. Artif Cells Nanomed Biotechnol. 2019;47:674–684.
  • Zschauer TC, Kunze K, Jakob S, et al. Oxidative stress-induced degradation of thioredoxin-1 and apoptosis is inhibited by thioredoxin-1-actin interaction in endothelial cells. Arterioscler Thromb Vasc Biol. 2011;31:650.
  • Karp JM, Leng TG. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 2009;4:206
  • Bantubungi K, Blum D, Cuvelier L, et al. Stem cell factor and mesenchymal and neural stem cell transplantation in a rat model of Huntington's disease. Mol Cell Neurosci. 2008;37:454–470.
  • Bandow K, Nishikawa Y, Ohnishi T, et al. Low-intensity pulsed ultrasound (LIPUS) induces RANKL, MCP-1, and MIP-1beta expression in osteoblasts through the angiotensin II type 1 receptor. J Cell Physiol. 2007;211:392–398.
  • Kennedy A. Fetal ultrasound. Curr Prob Diagn Radiol. 2000;29:109, 112–109, 140.
  • Veis A, Kougias K, Tsirlis A, et al. Evaluation of the osteogenic potential in experimental defects, with and without bone marrow, in the rabbit tibia: a pilot study. Int J Oral Maxillofac Implants. 2009;24:1054–1060.
  • Gao Y, Li C, Wang H, et al. Acceleration of bone-defect repair by using A-W MGC loaded with BMP2 and triple point-mutant HIF1α-expressing BMSCs. J Orthop Surg Res. 2015;10:83.
  • Caiment F, Gaj S, Claessen S, et al. High-throughput data integration of RNA–miRNA–circRNA reveals novel insights into mechanisms of benzo[a]pyrene-induced carcinogenicity. Nucleic Acids Res. 2015;43:2525–2534.
  • Boggs AE, Vitolo MI, Whipple RA, et al. α-Tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migration. Cancer Res. 2015;75:203–215.
  • Lei N, Wang P, Meng Q. Tm7sf2 may participate in the healing of burn wounds. Mol Med Rep. 2016;14:1002.
  • Aldinucci D, Colombatti A. The inflammatory chemokine CCL5 and cancer progression. Mediators Inflammation. 2014;2014:1.
  • Chen L, Vicente-Manzanares M, Potvin-Trottier L, et al. The integrin-ligand interaction regulates adhesion and migration through a molecular clutch. PLoS One. 2012;7:e40202.
  • Danciu TE, Gagari E, Adam RM, et al. Mechanical strain delivers anti-apoptotic and proliferative signals to gingival fibroblasts. J Dent Res. 2004;83:596–601.
  • Hu X-T, Zhang F-B, Fan Y-C, et al. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer. Oncogene. 2009;28:2466–2475.
  • Han Z, Guo J, Conley SM, et al. Retinal angiogenesis in the Ins2 (Akita) mouse model of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2013;54:574–584.
  • Ley K, Rivera-Nieves J, Sandborn WJ, et al. Integrin-based therapeutics: biological basis, clinical use and new drugs. Nat Rev Drug Discov. 2016;15:173–183.
  • Lu M, Munger JS, Steadele M, et al. Integrin alpha8beta1 mediates adhesion to LAP-TGFbeta1. J Cell Sci. 2002;115:4641–4648.
  • Fang X, Liu X, Yao L, et al. New insights into FAK phosphorylation based on a FAT domain-defective mutation. PLoS One. 2014;9:e107134
  • Subauste MC, Pertz O, Adamson ED, et al. Vinculin modulation of paxillin–FAK interactions regulates ERK to control survival and motility. J Cell Biol. 2004;165:371–381.
  • Hamadi A, Bouali M, Dontenwill M, et al. Regulation of focal adhesion dynamics and disassembly by phosphorylation of FAK at tyrosine 397. J Cell Sci. 2005;118:4415–4425.
  • Klemke RL, Cai S, Giannini AL, et al. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol. 1997;137:481–492.
  • Nguyen DH, Catling AD, Webb DJ, et al. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J Cell Biol. 1999;146:149–164.
  • Zhu L, Li C, Du G, et al. High glucose upregulates myosin light chain kinase to induce microfilament cytoskeleton rearrangement in hippocampal neurons. Mol Med Rep. 2018;18:216–222.